Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes

Jan Henrik Schirmer*, Jan Phillip Bremer, Frank Moosig, Julia Ulrike Holle, Peter Lamprecht, Stefan Wieczorek, Sierk Haenisch, Ingolf Cascorbi

*Corresponding author for this work
23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology